Pharmacological interventions for psoriatic arthritis: present and future.
Psoriatic arthritis is a common, chronic inflammatory arthritis that affects 5-7% of patients with psoriasis. Psoriatic arthritis is often treated in the same manner and with the same drugs as rheumatoid arthritis is. Currently much attention is being focused on the role of agents that inhibit the activity of pro-inflammatory cytokines, such as tumor necrosis factor a, which are believed to play a key role in joint destruction. The objective of this article is to review these newer developments besides taking a fresh look at the existing methods of therapy of this potentially disabling disorder.